TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
Status: | Completed |
---|---|
Conditions: | Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 12 - 45 |
Updated: | 10/14/2017 |
Start Date: | July 2006 |
End Date: | December 2011 |
TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)
The purpose of this study is to optimize several multi-dose regimens of otelixizumab,
determine the highest biologically active dose, evaluate biomarkers and surrogates of
efficacy, and to evaluate the effects of each multi-dose regimen of otelixizumab against
standard safety and efficacy parameters.
determine the highest biologically active dose, evaluate biomarkers and surrogates of
efficacy, and to evaluate the effects of each multi-dose regimen of otelixizumab against
standard safety and efficacy parameters.
Inclusion Criteria:
- Adults 12 to 45 years old who are in good general health
- Confirmed diagnosis of insulin requiring type 1 diabetes mellitus with good glycemic
control
- Measurable C-peptide levels
Exclusion Criteria:
- Females must not be pregnant or lactating and willing to practice contraception
- No prior malignancy, other than non-melanoma skin cancer
- Body Mass Index (BMI) > 32 at screening
We found this trial at
17
sites
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials
